Autophagy and Akt promote survival in glioma

 Abstract

Signaling through phosphatidylinositol 3-kinase (PtdIns3K)-Akt-mTOR is frequently activated in cancers including glioblastoma multiforme (GBM), where this kinase network regulates survival. It is thus surprising that inhibitors of these pathways induce minimal cell death in glioma. We showed that the dual PtdIns3K-mTOR inhibitor PI-103 induces autophagy in therapy-resistant, PTEN-mutant glioma, with blockade of mTOR complex 1 (mTORC1) and complex 2 (mTORC2) contributing independently to autophagy. Inhibition of autophagosome maturation synergizes with PI-103 to induce apoptosis through the Bax-dependent intrinsic mitochondrial pathway, indicating that PI-103 induces autophagy as a survival pathway in this setting. Not all inhibitors of PtdIns3K-Akt-mTOR signaling synergize with inhibitors of autophagy. The allosteric mTORC1 inhibitor rapamycin fails to induce apoptosis in conjunction with blockade of autophagy, due to feedback-activation of Akt. Apoptosis in the setting of rapamycin therapy requires concurrent inhibition of both autophagy and of PtdIns3K-Akt. Moreover, the clinical PtdIns3K-mTOR inhibitor NVP-BEZ235 cooperates with the clinical lysosomotropic autophagy inhibitor chloroquine to induce apoptosis in PTEN-mutant glioma xenografts in vivo, offering a therapeutic approach translatable to patients.

 Related Article:

CH Eng, K Yu, J Lucas, E White, RT Abraham. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal 0.
PMID: 21062993 DOI: 10.1126/scisignal.20

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
536 - 538
doi
10.4161/auto.7.5.14779
Type
Autophagic Punctum
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Autophagy and Akt promote survival in glioma